OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
161 hedge funds and large institutions have $564M invested in Orexigen Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 50 increasing their positions, 51 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
33% less capital invested
Capital invested by funds: $843M → $564M (-$278M)
Holders
161
Holding in Top 10
4
Calls
$7.84M
Puts
$5.37M
Top Buyers
| 1 | +$15M | |
| 2 | +$14.4M | |
| 3 | +$12.2M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$11.9M |
| 5 |
Millennium Management
New York
|
+$11.9M |
Top Sellers
| 1 | -$28.3M | |
| 2 | -$16M | |
| 3 | -$9.29M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$8.81M |
| 5 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$7.83M |